Nova Patents
ZA926837B

A pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist

Abstract

The present invention is a pharmaceutical composition having a combination of an uricosuric agent such as probenecid or the like and an excitatory amino acid antagonist useful for treating a disease advantageously affected by treatment with an excitatory amino acid antagonist.

Term

Term ended

Expired 8 September 2012, 14 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

27 members in 16 offices

This recordMember, by publication datePriority claim6 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
75640191United States of AmericaA

Members27

Family members, oldest first
DocumentOfficeKind
CA2115442A1CanadaA1
WO9304688A1World Intellectual Property Organization (WIPO)A1
AU2594392AAustraliaA
MX9205127AMexicoA
PT100850APortugalA
NO940809D0NorwayD0
NO940809LNorwayL
ZA926837BThis recordSouth AfricaB
EP0603301A1European Patent Office (EPO)A1
JPH06510544AJapanA
US5407935AUnited States of AmericaA
AU660717B2AustraliaB2
NZ244243ANew ZealandA
US5627168AUnited States of AmericaA
EP0603301B1European Patent Office (EPO)B1
AT162075TAustriaT
DE69224069D1GermanyD1
ES2113957T3SpainT3
US5767119AUnited States of AmericaA
GR3026369T3GreeceT3
DE69224069T2GermanyT2
DK0603301T3DenmarkT3
PT100850BPortugalB
US5942513AUnited States of AmericaA
NO307645B1NorwayB1
JP3218038B2JapanB2
CA2115442CCanadaC